EUVIMEDEUVIMED entdecken
Multizentrische Studie

Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease

Talat Bessissow, Neeraj Narula, Christopher Ma, Tracy S H In, Eneda Pone, Maria Eberg, Vipul Jairath, Canadian IBD Research Consortium

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2024.04.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Talat Bessissow und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. Electronic address: talat.bessissow@mcgi…. Hauptthemen laut MEDLINE: Ustekinumab, Crohn Disease, Hospitalization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Janssen Canada, Pfizer, Ferring Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UstekinumabCrohn DiseaseHospitalizationHumansFemaleMaleRetrospective StudiesCanadaAdultMiddle AgedSeverity of Illness IndexRemission InductionHealth ResourcesPatient Acceptance of Health Care

Stichwörter der Autor:innen

Crohn's diseaseReal-world studyUstekinumab

Substanzen

Ustekinumab

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. Electronic address: talat.bessissow@mcgill.ca.
  • McMaster University, Hamilton, ON, Canada.
  • University of Calgary, Calgary, AB, Canada.
  • Janssen Inc., Toronto, ON, Canada.
  • IQVIA Solutions Canada Inc., Kirkland, QC, Canada.
  • Western University, London, ON, Canada.

Förderung

  • Janssen Canada
  • Pfizer
  • Ferring Pharmaceuticals

Zitieren

APA

Bessissow, T., Narula, N., Ma, C., In, T. S. H., Pone, E., Eberg, M., Jairath, V., & Canadian IBD Research Consortium (2024). Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.04.017

Vancouver

Bessissow T, Narula N, Ma C, In TSH, Pone E, Eberg M, et al. Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.04.017

BibTeX
@article{Bessissow2024,
  author = {Bessissow, Talat and Narula, Neeraj and Ma, Christopher and In, Tracy S H and Pone, Eneda and Eberg, Maria and Jairath, Vipul and Canadian IBD Research Consortium, Canadian IBD Research Consortium},
  title = {Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2024.04.017}
}
Kostenlos starten →